Mitsuo Sawai
Algemeen Directeur bij SAWAI GROUP HOLDINGS CO., LTD.
Vermogen: 40 M $ op 30-04-2024
Actieve functies van Mitsuo Sawai
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SAWAI GROUP HOLDINGS CO., LTD. | Algemeen Directeur | 01-04-2021 | - |
| Voorzitter | 01-04-2021 | - | |
Sawai Pharmaceutical Co., Ltd.
 Sawai Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sawai Pharmaceutical Co., Ltd. engages in the manufacture and sale of prescription pharmaceutical products. Its products include cardiovascular drugs, antihyperlipidemic agents, diabetes, anticancer drugs, and over-the-counter drugs. It operates through the Japan and United States segments. The Japan segment sells manufactured pharmaceuticals to domestic sales companies, wholesale stores and other pharmaceutical manufacturers, as well as directly to medical institutions. The United States segment comprises of holding companies that manages subsidiaries and sell manufactured pharmaceuticals to wholesale stores in the United States. The company was founded by Hanpei Sawai and Noyo Sawai on April 1, 1929 and is headquartered in Osaka, Japan. | Voorzitter | 23-06-2020 | - |
| Directeur/Bestuurslid | 01-06-2000 | 23-06-2020 | |
| President | 01-06-2008 | 23-06-2020 | |
| Verkoop & Marketing | 01-06-2000 | 01-06-2008 |
Loopbaan van Mitsuo Sawai
Statistieken
Internationaal
| Japan | 3 |
Operationeel
| Chairman | 2 |
| Director/Board Member | 1 |
| President | 1 |
Sectoraal
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SAWAI GROUP HOLDINGS CO., LTD. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Sawai Pharmaceutical Co., Ltd.
Sawai Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sawai Pharmaceutical Co., Ltd. engages in the manufacture and sale of prescription pharmaceutical products. Its products include cardiovascular drugs, antihyperlipidemic agents, diabetes, anticancer drugs, and over-the-counter drugs. It operates through the Japan and United States segments. The Japan segment sells manufactured pharmaceuticals to domestic sales companies, wholesale stores and other pharmaceutical manufacturers, as well as directly to medical institutions. The United States segment comprises of holding companies that manages subsidiaries and sell manufactured pharmaceuticals to wholesale stores in the United States. The company was founded by Hanpei Sawai and Noyo Sawai on April 1, 1929 and is headquartered in Osaka, Japan. | Health Technology |
- Beurs
- Insiders
- Mitsuo Sawai
- Ervaring